Litigation

Recent Posts

First New Jersey Levaquin Tendon Injury Trial Ends With Defense Verdict
Posted on 14 Oct 2011 by Tom Moylan

ATLANTIC CITY, N.J. - (Mealey's) The first trial in New Jersey's Levaquin mass tort litigation ended Oct. 14 with a defense verdict for Johnson & Johnson and subsidiary Ortho-McNeil-Janssen Pharmaceuticals Inc. ( Paul Gaffney v. Johnson &... Read More

2nd Levaquin/Tendon Rupture MDL Trial Ends In Defense Verdict
Posted on 20 Jun 2011 by Tom Moylan

MINNEAPOLIS -- The second trial in the Levaquin antibiotic multidistrict litigation ended in a defense verdict June 17 when a jury in the U.S. District Court for the District of Minnesota found that defendant Ortho-McNeil-Janssen Pharmaceuticals Inc.... Read More

Levaquin Compensatory Verdict Affirmed By 8th Circuit; Punitive Verdict Reversed
Posted on 3 Dec 2012 by Tom Moylan

ST. LOUIS — (Mealey’s) The Eighth Circuit U.S. Court of Appeals on Nov. 30 unanimously affirmed denial of judgment as a matter of law or new trial for compensatory damages in the first Levaquin multidistrict litigation bellwether trial but... Read More

Jury Awards $1.8 Million To Plaintiff In First Levaquin MDL Bellwether Trial
Posted on 9 Dec 2010 by Tom Moylan

MINNEAPOLIS - (Mealey's) A Minnesota federal jury on Dec. 8 awarded a plaintiff in the first Levaquin multidistrict litigation bellwether trial a total of $1,815,000 in compensatory and punitive damages after finding that manufacturer Ortho-McNeil... Read More

Court Rejects Pfizer Appeal Of Nigerians' Lawsuits
Posted on 29 Jun 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court is staying out of a dispute between Nigerian families and Pfizer, Inc., over the drug maker's use of a new antibiotic on children during a deadly outbreak of meningitis in the mid-1990s. The justices on Tuesday... Read More

Glaxo Settles Bad Drug Claim For More Than $40 Million
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered... Read More